Related Experiment Videos
Thaliporphine, a positive inotropic agent with a negative chronotropic action
1Department of Pharmacology, College of Medicine, National Taiwan University, Taipei.
European Journal of Pharmacology
|March 11, 1994
Summary
Thaliporphine enhances cardiac muscle contractions and prolongs action potential duration by blocking sodium (Na+) and potassium (K+) channels, acting as a weak calcium (Ca2+) channel agonist.
Area of Science:
- Pharmacology
- Cardiovascular Physiology
- Electrophysiology
Background:
- Cardiac electrophysiology and contractility are critical determinants of heart function.
- Understanding the effects of novel compounds on ion channels is essential for developing new cardiovascular therapies.
Purpose of the Study:
- To investigate the effects of thaliporphine on cardiac contractility and electrophysiological properties.
- To elucidate the specific ion channel mechanisms underlying thaliporphine's actions.
Main Methods:
- Experiments were conducted on isolated rat atria and ventricular strips, as well as atrial and ventricular cells from rats and guinea pigs.
- Twitch tension, action potential parameters, and ionic currents (Ito, Ik, INa, ICa) were measured using electrophysiological techniques.
Main Results:
- Thaliporphine increased twitch tension dose-dependently, indicating a positive inotropic effect.
- It inhibited the action potential upstroke, prolonged action potential duration, and reduced transient outward (Ito) and delayed rectifier (Ik) potassium currents.
- Thaliporphine also reduced sodium inward current (INa) and acted as a weak calcium channel agonist, increasing calcium inward current (ICa).
Conclusions:
- Thaliporphine exhibits potent Na+ and K+ channel blocking activities and weak Ca2+ channel agonism.
- The positive inotropic effect is likely due to increased calcium entry or K+ efflux inhibition, while K+ efflux inhibition contributes to a negative chronotropic effect.